With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott's Duphaston
from Latest News https://ift.tt/3uYyPZa
Monday, 19 April 2021
Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment